Sachs Jessica 4
4 · Cogent Biosciences, Inc. · Filed Jul 1, 2022
Insider Transaction Report
Form 4
Sachs Jessica
Chief Medical Officer
Transactions
- Award
Common Stock
2022-06-30$7.39/sh+622$4,600→ 622 total
Footnotes (1)
- [F1]The shares were acquired under the Cogent Biosciences, Inc. 2018 Employee Stock Purchase Plan. The transaction is exempt under both Rule 16b-3(d) and Rule 16b-3(c).